A detailed history of Douglas Lane & Associates, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 1,622 shares of BDX stock, worth $363,328. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,622
Previous 1,745 7.05%
Holding current value
$363,328
Previous $407,000 3.93%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$221.47 - $242.41 $27,240 - $29,816
-123 Reduced 7.05%
1,622 $391,000
Q2 2024

Jul 08, 2024

BUY
$225.07 - $246.17 $40,962 - $44,802
182 Added 11.64%
1,745 $407,000
Q1 2024

Apr 11, 2024

BUY
$233.45 - $247.73 $4,202 - $4,459
18 Added 1.17%
1,563 $386,000
Q4 2023

Jan 17, 2024

SELL
$232.24 - $267.23 $29,030 - $33,403
-125 Reduced 7.49%
1,545 $376,000
Q3 2023

Oct 16, 2023

SELL
$254.9 - $283.59 $1,529 - $1,701
-6 Reduced 0.36%
1,670 $431,000
Q2 2023

Jul 19, 2023

SELL
$238.39 - $265.32 $7,151 - $7,959
-30 Reduced 1.76%
1,676 $442,000
Q1 2023

Apr 17, 2023

SELL
$229.71 - $259.35 $5,742 - $6,483
-25 Reduced 1.44%
1,706 $422,000
Q4 2022

Jan 17, 2023

SELL
$218.29 - $256.91 $21,829 - $25,691
-100 Reduced 5.46%
1,731 $440,000
Q3 2022

Oct 14, 2022

SELL
$51.03 - $264.23 $510 - $2,642
-10 Reduced 0.54%
1,831 $408,000
Q2 2022

Jul 18, 2022

SELL
$234.74 - $275.42 $17,840 - $20,931
-76 Reduced 3.96%
1,841 $454,000
Q1 2022

Apr 25, 2022

SELL
$243.64 - $270.48 $17,542 - $19,474
-72 Reduced 3.62%
1,917 $510,000
Q4 2021

Jan 25, 2022

SELL
$230.08 - $250.94 $44,405 - $48,431
-193 Reduced 8.85%
1,989 $500,000
Q2 2021

Jul 19, 2021

SELL
$232.65 - $254.58 $25,591 - $28,003
-110 Reduced 4.8%
2,182 $531,000
Q1 2021

Apr 19, 2021

SELL
$232.09 - $256.88 $45,257 - $50,091
-195 Reduced 7.84%
2,292 $557,000
Q4 2020

Jan 14, 2021

BUY
$221.92 - $245.94 $5,548 - $6,148
25 Added 1.02%
2,487 $622,000
Q3 2020

Oct 19, 2020

BUY
$215.77 - $276.76 $4,099 - $5,258
19 Added 0.78%
2,462 $573,000
Q2 2020

Jul 28, 2020

BUY
$219.9 - $263.41 $10,335 - $12,380
47 Added 1.96%
2,443 $585,000
Q1 2020

Apr 20, 2020

SELL
$195.69 - $279.01 $63,599 - $90,678
-325 Reduced 11.94%
2,396 $551,000
Q4 2019

Jan 27, 2020

SELL
$236.45 - $266.82 $24,354 - $27,482
-103 Reduced 3.65%
2,721 $740,000
Q3 2019

Oct 16, 2019

BUY
$230.58 - $256.08 $81,625 - $90,652
354 Added 14.33%
2,824 $714,000
Q2 2019

Jul 08, 2019

SELL
$217.4 - $246.08 $3,695 - $4,183
-17 Reduced 0.68%
2,470 $622,000
Q1 2019

Apr 23, 2019

SELL
$206.05 - $248.17 $6,593 - $7,941
-32 Reduced 1.27%
2,487 $621,000
Q4 2018

Jan 17, 2019

SELL
$204.73 - $257.93 $409 - $515
-2 Reduced 0.08%
2,519 $568,000
Q3 2018

Oct 09, 2018

BUY
$233.07 - $256.0 $89,965 - $98,816
386 Added 18.08%
2,521 $658,000
Q2 2018

Jul 23, 2018

SELL
$208.1 - $233.85 $43,909 - $49,342
-211 Reduced 8.99%
2,135 $511,000
Q1 2018

Apr 23, 2018

BUY
$205.46 - $240.27 $10,273 - $12,013
50 Added 2.18%
2,346 $508,000
Q4 2017

Jan 24, 2018

SELL
$189.0 - $222.64 $4,725 - $5,566
-25 Reduced 1.08%
2,296 $491,000
Q3 2017

Oct 19, 2017

BUY
$186.89 - $198.9 $433,771 - $461,646
2,321
2,321 $455,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Douglas Lane & Associates, LLC Portfolio

Follow Douglas Lane & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.